OREANDA-NEWS. June 02, 2014. FAS, together with the leading experts in parenteral nutrition and market participants, determined the substitutability criteria for the medicines for parenteral nutrition.

“PharmAkta. Quality and Standards” Non-Profit Partnership was the initiator of approaching the antimonopoly body. According to the petition, on the market of medicines for parenteral nutrition there is a need to explain to the government customers the specifics of procurement of polycomponent medicines since such drugs wither do not have an international non-proprietary name or it is replaced with a generic name.

“Applying the substitutability criteria for the medicines for parenteral nutrition, devised by the Antimonopoly Service jointly with the experts, by the government customers will clarify the tender documents, and positively affect the state of competition on the markets, which will reduce the costs of contracts", concluded the Head of FAS Department for Control over Social Sphere and Trade, Timophei Nizhegorodtsev.

Parenteral nutrition is a method of introducing nutrients to the body by intravenous infusion by-passing gastro-intestinal tract. It is used when patients are unable to feed themselves independently.